OCC 2.74% 35.5¢ orthocell limited

Ann: Orthocell commences nerve repair study, page-5

  1. 7,509 Posts.
    lightbulb Created with Sketch. 6763
    One day this company will get some decent coverage:

    https://hotcopper.com.au/data/attachments/5212/5212931-438549e1df6ef2422482390f605621a5.jpg
    This is a big deal. FDA approval in Striate quickly followed the Striate comparator study....Remplir should be going to market in the US by 2024....and Striate will already be selling well as Bio HOorizons continues it as its leading biological in its sales thrust....
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
-0.010(2.74%)
Mkt cap ! $74.31M
Open High Low Value Volume
36.0¢ 36.5¢ 35.5¢ $78.83K 220.6K

Buyers (Bids)

No. Vol. Price($)
1 1813 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 2400 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.